Nautilus Biotechnology, Inc. (NAUT)
2.735
-0.40
(-12.90%)
USD |
NASDAQ |
Oct 30, 16:00
2.74
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Gross Profit Margin (Quarterly) : -467.5% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -467.5% |
| Date | Value |
|---|---|
| June 30, 2026 | -583.7% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 55.48% |
| Bio-Rad Laboratories, Inc. | 53.12% |
| Bruker Corp. | 49.65% |
| Danaher Corp. | 59.34% |
| Harvard Bioscience, Inc. | 51.96% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.78% |
| Return on Assets | -33.20% |
| Return on Invested Capital | -34.11% |
| Profit Margin (Quarterly) | -6.68K% |
| Operating Margin (Quarterly) | -7.15K% |
| Return on Net Operating Assets | -196.2% |